Cargando…
Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
Autores principales: | O’Connell, Jim, Doherty, Jayne, Buckley, Amy, Cormican, David, Dunne, Cara, Hartery, Karen, Larkin, John, MacCarthy, Finbar, McCormick, Paul, McKiernan, Susan, Mehigan, Brian, Muldoon, Cian, Ryan, Ciara, O’Sullivan, Jacintha, Kevans, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344240/ https://www.ncbi.nlm.nih.gov/pubmed/35263959 http://dx.doi.org/10.5217/ir.2021.00073 |
Ejemplares similares
-
Effect of cigarette smoke extract on the intestinal microenvironment of ulcerative colitis tissue
por: Cannon, Aoife, et al.
Publicado: (2020) -
Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
por: Minar, Phillip, et al.
Publicado: (2019) -
Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors
por: Kennedy, Susan A., et al.
Publicado: (2020) -
Sigmoid volvulus: definitive surgery is safe and should be considered in all instances
por: Hardy, Niall P., et al.
Publicado: (2021) -
The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses
por: Heeran, Aisling B., et al.
Publicado: (2021)